Pharma giant Bayer will invest $2.2B in a New Albany, Ohio manufacturing campus for oncology and cardiovascular drugs, ...
Helping Downstream Processing To Follow Upstream Innovation. Complex biomolecules place unprecedented demands on conventional ...
Reduced-volume bioburden testing represents a practical and defensible approach for low-volume, high-value cell and gene ...
Sanofi says integrated continuous purification is a “universal solution” for downstream processing as it prepares for ...
University students attended Biotech Week Boston Campus to learn about career options in a volatile biopharma industry and ...
Allogeneic cell therapies offer scalability but require expanded infrastructure to build a viable commercial foundation ...
Examine the use of CHT™ XT Media, a ceramic hydroxyapatite mixed-mode resin, to facilitate purification of various large ...
Dan is currently a trade media relations expert at Sartorius, and he formerly led the news domain of Bioprocess International ...
Drug sponsors seek to capitalize on opportunities created by streamlined regulations for biosimilar characterization.
The successful European Medicines Agency inspection is the latest in a string of positive news for the big Chinese biotech ...
Enabling Widespread Adoption of Transformative Biopharmaceutical Technologies: Insights from Roundtable 1 of the 2025 BioInnovation Group Executive Summit Summarizing insights from the first of six ...
Astellas is set to restart trials for its age-related macular degeneration (AMD) program ASP7317 after improving production and analytical process for the embryonic stem cell-derived candidate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results